Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
By Prakhar Srivastava and Pritam Biswas (Reuters) -Metsera, which is developing weight-loss drugs, said on Monday it is seeking a…
By Prakhar Srivastava and Pritam Biswas (Reuters) -Metsera, which is developing weight-loss drugs, said on Monday it is seeking a…
By Anushree Mukherjee (Reuters) – Gold prices look set for a record-breaking 2025 as heightened economic uncertainty and inflation concern…
By Stephen Nellis SAN FRANCISCO (Reuters) -Nvidia on Monday said Chinese AI firm DeepSeek’s advances show the usefulness of its…
By Suzanne McGee (Reuters) -Prices of exchange-traded funds with outsize exposure to Nvidia plunged on Monday in reaction to news…
By David Ljunggren (Reuters) – Two senior Republican senators on Sunday urged U.S. President Donald Trump to rethink his decision…
By Phil Stewart WASHINGTON (Reuters) – U.S. President Donald Trump’s order halting diversity, equity and inclusion initiatives has led the…
By Kanishka Singh WASHINGTON (Reuters) – A public teacher in Pennsylvania was put on leave after allegedly calling a Palestinian…
WASHINGTON (Reuters) – Vice President JD Vance said bureaucrats at U.S. intelligence services were “out of control” and he defended…
By Andrew Goudsward and Nate Raymond WASHINGTON (Reuters) – The U.S. Justice Department’s new leadership under President Donald Trump ordered…
By Emma-Victoria Farr FRANKFURT (Reuters) – Elon Musk made a surprise appearance during Germany’s AfD (Alternative fuer Deutschland) election campaign…